CytRx Corporation to Present at the H.C. Wainwright & Co. 20th Annual ...


CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today announced that Mr. Eric Curtis, President and Chief Operating Officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference. The presentation will occur on Wednesday, September 5 at 11:40 A.M. Eastern Daylight Time at the St. Regis Hotel in New York City.



from Biotech News